肿瘤是困扰人类已久的顽疾,有关于肿瘤治疗方法的研究也日趋深入。近年来,随着生物学技术的发展,特别是细胞工程和基因工程技术的发展,肿瘤抗原的基因结构和人工合成技术也取得了相应进展,这也使得肿瘤基因疫苗成了众多学者研究的热点。 科学家经多年研究发现在细胞癌变的过程中可以出现肿瘤抗原(即新生抗原),肿瘤基因疫苗即是以相应肿瘤抗原肽的基因结构为基础制得。所谓肿瘤基因疫苗(即DNA疫苗)是将编码某种肿瘤抗原 Tumor is a chronic illness plaguing humans for a long time, and research on the treatment of tumors has also been deepening. In recent years, with the development of biological technology, especially the development of cell engineering and genetic engineering technology, the genetic structure of tumor antigens and artificial synthesis technology have also made corresponding progress, which also makes the tumor gene vaccine become the hotspot of many scholars . After years of research, scientists have found that tumor antigens (ie, nascent antigens) can occur during canceration of the cells. The tumor gene vaccine is based on the gene structure of the corresponding tumor antigen peptide. The so-called tumor gene vaccine (DNA vaccine) is to encode a tumor antigen